Information  X 
Enter a valid email address

Virotec Intl. PLC (VTI)

  Print      Mail a friend

Friday 16 February, 2007

Virotec Intl. PLC

Holding(s) in Company

Virotec International PLC
16 February 2007

                           VIROTEC INTERNATIONAL PLC

16 February 2007

                            MAJOR INTEREST IN SHARES

On 15 February 2007, Virotec International plc (the 'Company') (AIM: VTI)
received notification as required by Section DTR5 of the FSA's Disclosure &
Transparency Rules, in relation to holdings in the Company of entities owned or
managed by Aviva plc of PO Box 89, Surry Street, Norwich NR1 3DR.

The notification provided a restatement of historic interests in compliance with
the FSA's new rules, and advised as follows:

Class of     Name                       Holder's votes   Nature    Voting Power
securities                                               of holding
           BNP Paribas - London             1,399,910    Indirect                        
Ordinary   BNY Norwich Union Nominees       1,575,751    Direct
shares      Limited                                                             
           Chase GA Group Nominees Limited  4,081,257    Direct
           Chase Nominees Limited             458,000    Direct
           CUIM Nominee Limited             2,505,836    Direct     
           State Street Nominees Limited    3,750,000    Indirect     
           Vidacos Nominees Limited         7,559,500    Indirect   Direct 3.59% 
           CUIM  Nominee Limited            7,132,856    Indirect Indirect 8.26%
                                                         
                     Total                 28,463,110                    11.85%


If you require further information please contact Angus Craig, Company
Secretary, on telephone +617 5530 8014.




                           VIROTEC INTERNATIONAL PLC
                                   PO BOX 188
                            SANCTUARY COVE QLD 4212
                                   AUSTRALIA
                                www.virotec.com







                      This information is provided by RNS
            The company news service from the London Stock Exchange